Glucocorticoid regulation of a novel HPV-E6-p53-miR-145 pathway modulates invasion and therapy resistance of cervical cancer cells

Regulation of cellular miRNA expression by human papillomaviruses

(2011) Zhi-Ming Zheng et al.   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms

Growth inhibition by microRNAs that target the insulin receptor substrate-1

(2011) Gaspare La Rocca et al.   CELL CYCLE

p53 and c-myc: How does the cell balance “yin” and “yang”?

(2011) Mohit Sachdeva et al.   CELL CYCLE

The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop

(2011) A. Menssen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The pain, depression, and fatigue symptom cluster in advanced breast cancer: Covariation with the hypothalamic–pituitary–adrenal axis and the sympathetic nervous system.

(2010) Lisa M. Thornton et al.   HEALTH PSYCHOLOGY

Cancer: The blind spot of p53

(2010) Anton Berns   NATURE

MicroRNA-145 Suppresses Cell Invasion and Metastasis by Directly Targeting Mucin 1

(2009) M. Sachdeva et al.   CANCER RESEARCH

Modulation of microRNA processing by p53

(2009) Hiroshi I. Suzuki et al.   NATURE

Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy

(2009) Magdalena Sarasin-Filipowicz et al.   NATURE MEDICINE

p53 represses c-Myc through induction of the tumor suppressor miR-145

(2009) M. Sachdeva et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Insulin-like growth factor-1 attenuates cisplatin-induced γH2AX formation and DNA double-strand breaks repair pathway in non-small cell lung cancer

(2008) Jeong Hee Jeon et al.   CANCER LETTERS

The insulin receptor substrate-1: A biomarker for cancer?

(2008) Renato Baserga   EXPERIMENTAL CELL RESEARCH

Serum withdrawal up-regulates humanSIRT1gene expression in a p53-dependent manner

(2008) Linshan Shang et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Aberrant Expression of Oncogenic and Tumor-Suppressive MicroRNAs in Cervical Cancer Is Required for Cancer Cell Growth

(2008) Xiaohong Wang et al.   PLoS One